IMMUNITYBIO, INC. Insurance Settlements Receivable, Current
IMMUNITYBIO, INC. (IBRX) had Insurance Settlements Receivable, Current of $0 as of 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Notes › Nontrade Receivables
us-gaap:InsuranceSettlementsReceivableCurrent · last filed 2025-03-03
- 2024-12-31: Insurance Settlements Receivable, Current $0.00.
- 2024-09-30: Insurance Settlements Receivable, Current $0.00.
- 2024-06-30: Insurance Settlements Receivable, Current $0.00.
- 2024-03-31: Insurance Settlements Receivable, Current $0.00.
| Period end | Insurance Settlements Receivable, Current | Insurance Settlements Receivable, Current as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-03 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.15M 10-K · filed 2025-03-03 | |
| 2023-06-30 | $1.25M 10-Q · filed 2023-08-08 | |
| 2022-12-31 | $0.00 10-K · filed 2024-03-19 | |
| 2022-09-30 | $5.00M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $5.00M 10-Q · filed 2022-08-08 | |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-09 | |
| 2021-09-30 | $92.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $2.93M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $2.52M 10-Q · filed 2021-11-12 | $0.00 10-K · filed 2021-03-04 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $29.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $6.38M 8-K/A · filed 2021-04-22 | $34.00K 10-K · filed 2020-03-25 |
| 2019-09-30 | $74.00K 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $294.00K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $11.14M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $10.88M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $12.99M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $1.93M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $1.58M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $340.00K 10-K · filed 2019-03-13 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |